Findings from this study suggest that targeting GPR88 could have beneficial effects in modulating fat accretion, feeding behavior, and glucose homeostasis in obesity-related comorbidities. This evidence concerns the gene GPR88 and obesity due to melanocortin 4 receptor deficiency.